Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Colon Cancer
- Breast Cancer
- Esophageal Cancer
- Gastrointestinal Cancer
- Genitourinary Cancer
- Head and Neck Cancer
- Healthy Volunteer
- Lung Cancer
- Skin Cancer
- Solid Tumor Cancer
- Melanoma
- Prostate Cancer
- Sarcoma
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Other
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04354064
- Collaborators
- Roche Sequencing Solutions
- The Foundation for Barnes-Jewish Hospital
- National Center for Advancing Translational Science (NCATS)
- Radiological Society of North America
- Skandalaris
- The V Foundation for Cancer Research
- Investigators
- Principal Investigator: Aadel Chaudhuri, M.D., Ph.D. Washington University School of Medicine